The aim of the study is to identify trends by analyzing the new antibacterial drugs approved by the EMA and FDA during the period 2020-2024, which can be used for planning antibiotic policies in healthcare institutions providing hospital care. The methodology of the study includes the collection and analysis of data from regulatory agencies and scientific sources on the antibiotics approved for use in the European Union and the USA during the study period.
Антибиотици: MedlinePlus [Internet]. [cited 2025 Mar 24]. Available from: https://medlineplus.gov/antibiotics.html
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 Feb 12;399(10325):629–55.
Antibiotic, antibacterial and antimicrobial – REVIVE [Internet]. [cited 2025 Apr 4]. Available from: https://revive.gardp.org/resource/antibiotic-antibacterial-and-antimicrobial/?cf=encyclopaedia
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 Feb 12;399(10325):629–55.
Antibiotics and antimicrobial resistance – a timeline — Science Learning Hub [Internet]. [cited 2025 Mar 25]. Available from: https://www.sciencelearn.org.nz/interactive_timeline/15-antibiotics-and-antimicrobial-resistance-a-timeline
Ishak A, Mazonakis N, Spernovasilis N, Akinosoglou K, Tsioutis C. Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. Journal of Antimicrobial Chemotherapy [Internet]. 2025 Jan 3 [cited 2025 Mar 24];80(1):1–17. Available from: https://dx.doi.org/10.1093/jac/dkae380
Patel P, Wermuth HR, Calhoun C, Hall GA. Antibiotics. Chronic Rhinosinusitis: the Mucosal Concept [Internet]. 2023 May 26 [cited 2025 Mar 25];341–53. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535443/
Oxford Textbook of Medicine: Infection - Google Books [Internet]. [cited 2025 Mar 27]. Available from: https://books.google.bg/books?id=hEjqD-ygu8AC&pg=PA39&redir_esc=y#v=onepage&q&f=false
Hopkins ABX Ръководство [Internet]. [cited 2025 Mar 24]. Available from: https://www.hopkins-abxguide.org/
Видове бактерии | Грам-положителни и грам-отрицателни бактерии [Internet]. [cited 2025 Mar 24]. Available from: https://www.antibioticresearch.org.uk/about-antibiotic-resistance/bacterial-infections/types-of-bacteria/
ATCDDD - Начало [Internet]. [cited 2025 Mar 20]. Available from: https://atcddd.fhi.no/
Анатомична терапевтична химична (ATC) класификация [Internet]. [cited 2025 Mar 24]. Available from: https://www.who.int/tools/atc-ddd-toolkit/atc-classification
FDA approves new treatment for complicated urinary tract and complicated intra-abdominal infections | FDA [Internet]. [cited 2025 Mar 25]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-treatment-complicated-urinary-tract-and-complicated-intra-abdominal-infections
Recarbrio | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 25]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/recarbrio
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs | FDA [Internet]. [cited 2025 Mar 26]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-resistant-forms-tuberculosis-affects-lungs
Dovprela (previously Pretomanid FGK) | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/dovprela
FDA approves new antibiotic to treat community-acquired bacterial pneumonia | FDA [Internet]. [cited 2025 Mar 26]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-treat-community-acquired-bacterial-pneumonia
Union Register of medicinal products - Public health - European Commission [Internet]. [cited 2025 Mar 26]. Available from: https://ec.europa.eu/health/documents/community-register/html/h1457.htm
FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance | FDA [Internet]. [cited 2025 Mar 26]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-complicated-urinary-tract-infections-part-ongoing-efforts
Fetcroja | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/fetcroja
Novel Drug Approvals for 2023 | FDA [Internet]. [cited 2025 Mar 25]. Available from: https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2023
Sulbactam-Durlobactam - DocCheck Flexikon [Internet]. [cited 2025 Mar 26]. Available from: https://flexikon.doccheck.com/de/Sulbactam-Durlobactam
Allecra Therapeutics Announces U.S. FDA Approval for EXBLIFEP® for the Treatment of Complicated Urinary Tract Infections [Internet]. [cited 2025 Mar 26]. Available from: https://www.businesswire.com/news/home/20240227132611/en/Allecra-Therapeutics-Announces-U.S.-FDA-Approval-for-EXBLIFEP-for-the-Treatment-of-Complicated-Urinary-Tract-Infections#xd_co_f=OTI3NjkwNDUtMzI0NS00YmZlLWJkMTMtMmEzNTZjYWVmNTNk~
Exblifep | Европейска агенция по лекарствата (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/exblifep
FDA Approves New Antibiotic for Three Different Uses | FDA [Internet]. [cited 2025 Mar 26]. Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibiotic-three-different-uses
Chambers HF. Ceftobiprole: in-vivo profile of a bactericidal cephalosporin. Clinical Microbiology and Infection. 2006 Jan 1;12(SUPPL. 2):17–22.
Morosini MI, Díez-Aguilar M, Cantón R. Mechanisms of action and antimicrobial activity of ceftobiprole. Revista Española de Quimioterapia [Internet]. 2019 Sep 1 [cited 2025 Mar 25];32(Suppl 3):3. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC6755350/
Novel Drug Approvals for 2024 | FDA [Internet]. [cited 2025 Mar 25]. Available from: https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2024
Shaikh S, Fatima J, Shakil S, Rizvi SMD, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. Saudi J Biol Sci. 2015 Jan 1;22(1):90–101.
FDA approves combination antibiotic for difficult-to-treat infections | CIDRAP [Internet]. [cited 2025 Mar 26]. Available from: https://www.cidrap.umn.edu/antimicrobial-stewardship/fda-approves-combination-antibiotic-difficult-treat-infections
Emblaveo | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/emblaveo
Национален съвет по цени и реимбурсиране на лекарствените продукти [Internet]. [cited 2025 Apr 7]. Available from: https://portal.ncpr.bg/registers/
Recarbrio | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/recarbrio
Sheikhi N, Bahraminejad M, Saeedi M, Mirfazli SS. A review: FDA-approved fluorine-containing small molecules from 2015 to 2022. Eur J Med Chem. 2023 Nov 15;260:115758.
ATCDDD - ATC/DDD Index [Internet]. [cited 2025 Mar 26]. Available from: https://atcddd.fhi.no/atc_ddd_index/?code=J04AK08
Yuan S, Yu B, Liu HM. New drug approvals for 2019: Synthesis and clinical applications. Eur J Med Chem. 2020 Nov 1;205:112667.
Xenleta | European Medicines Agency (EMA) [Internet]. [cited 2025 Mar 26]. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/xenleta
Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, et al. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Drugs [Internet]. 2019 Feb 28 [cited 2025 Mar 25];79(3):271–89. Available from: https://pubmed.ncbi.nlm.nih.gov/30712199/
Al Musawa M, Bleick CR, Herbin SR, Caniff KE, Van Helden SR, Rybak MJ. Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens. Pharmacotherapy [Internet]. 2024 Dec 1 [cited 2025 Mar 25];44(12):927. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11687205/
Email this article (Login required) 
